NDAINJECTIONINJECTABLE
Lifecycle
Pre-Launch
Clinical Trials
3
Data completeness
3/8 — Basic
TRAVAMULSION 20% (soybean oil) by Baxter is patients, providing macronutrients (amino acids, dextrose and lipids) and micronutrients (electrolytes) parenterally. Approved for total parenteral nutrition-induced cholestasis, lactation, allergies.
Drug data last refreshed 2w ago
Mechanism of Action
patients, providing macronutrients (amino acids, dextrose and lipids) and micronutrients (electrolytes) parenterally. The amino acids provide the structural units that make up proteins and are used to synthesize proteins and other biomolecules or are oxidized to urea and carbon dioxide as a source…
Worked on TRAVAMULSION 20% at Baxter? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.